Core Scientific (CORZR) EBIT (2020 - 2026)

Core Scientific has disclosed EBIT across 7 years of filings, most recently posting -$310.4 million for Q1 2026.

• EBIT for Q1 2026 came in at -$310.4 million, down 559.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$509.0 million (down 108.31% YoY), and the FY2025 annual result was -$245.6 million, down 72.87% from the prior year.
• EBIT came in at -$310.4 million for Q1 2026 at Core Scientific, down from -$117.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $55.2 million in Q1 2024 to a low of -$1.0 billion in Q2 2022.
• The 5-year median for EBIT is -$47.0 million (2025), against an average of -$164.6 million.
• Across the five-year window, EBIT slumped 8489.92% in 2022 and surged 626.48% in 2024, its largest moves.
• Core Scientific's EBIT stood at -$636.1 million in 2022, then jumped by 100.62% to $3.9 million in 2023, then sank by 1762.2% to -$65.4 million in 2024, then tumbled by 79.65% to -$117.5 million in 2025, then sank by 164.25% to -$310.4 million in 2026.
• The last three EBIT figures came in at -$310.4 million (Q1 2026), -$117.5 million (Q4 2025), and -$54.8 million (Q3 2025), per Business Quant data.